Capturing Value: What business models are next for the biopharma world?
September 23-25, 2008
New York Marriott Downtown • New York City

Thank you to all our sponsors, speakers and attendees for making PSA a great success!

Registration Individual Registration Company Hotel Information 2008 Schedule Individual Registration: $1995 Company Registration: $1795 3 or more attendees, each Conference Sponsorship 2007 Attending Companies

Interested in presenting at a Windhover conference? Submit your idea here

It’s THE MOST senior level case studies for dealmaking and strategy available in the industry.

Windhover's 18th Annual Pharmaceutical Strategic Alliances is simply where you will meet the most important people in the business.

DON'T MISS
these top-level speakers! 

Even the optimists in the pharma and biotech worlds don’t see much future for business-models-as-usual. They may not agree on the model – but they agree that what we’ve got isn’t right. The 2008 PSA conference focuses on what’s next for the broader biopharma worlds – models that break down the walls between Big Pharma, biotech and spec pharma pipelines, and open up the financing opportunities to a much broader investment audience. PSA looks at these innovative ways of developing medicines and capturing value.

While Big Pharma struggles to think small, biotechs wrestle with how to get big – in value – without all that infrastructure.

So while Big Pharma tries to recreate biotech creativity, spins off research and products, cuts costs … biotech experiments with ways of dispensing with vertical interpretation. Is ripping apart the value chain the next step for both? As they do so, traditional pharmaceuticals will be at the very heart of the activity. You can follow – even shape – the actions at the industry’s most important strategy meeting: Pharmaceutical Strategic Alliances.

Maximize your strategic alliance opportunities by hearing CEOs, senior R&D and senior business development executives share lessons learned, practical advice and strategies on how to build your R&D pipeline – both internally and externally. Take away the newest strategies and tactics that you can apply to your company’s dealmaking efforts immediately!

And this September, PSA offers you an unbeatable line-up of Big Pharma and biotech speakers to forecast trends and analyze changes in alliances and M&A. You’ll hear from, and be able to quiz, top industry executives and dealmakers.

PSA gathers top thinkers to grapple with the fundamental challenges facing biotech and pharma – equipping dealmakers like you with the insights, information and practical advice you'll need to strike successful deals. This program will sell out so register early. Space is limited, so register today!

BEYOND THE BASICS! PSA attracts THE most strategic level speakers and audience. Past speakers include:

Richard Clark CEO Merck & Co. Fred Hassan CEO Schering-Plough Corp. Sidney Taurel CEO Eli Lilly and Company Dr. Peter S. Kim President Merck Research Laboratories

Elliott Sigal, MD, PhD EVP, CSO & President R&D Bristol-Myers Squibb Thomas Koestler, PhD EVP, Schering-Plough President, Schering-Plough Research Institute Dr. Lee Babiss Global Head of Pharma Research Roche Steven Marc Paul, M.D. EVP of Science and Technology and President of the Lilly Research Laboratories Eli Lilly and Co.

And as always, you’ll be able to network and exchange ideas with an elite group of your peers, your colleagues, your partners and your competitors.

Pharmaceutical Strategic Alliances is going to explore the different strategies of externalization, from the podium and in the hallways, in a depth you will experience at no other conference because we have the speakers and the attendees who set the strategies.

By attending PSA, you can:

What your colleagues and competitors have to say about Pharmaceutical Strategic Alliances:

See you at the New York Marriott Downtown, New York City, this Sept. 23-25!

Cancellation Policy: The last day to cancel your registration for a refund, minus a $300 processing fee, is August 22. After that, you may send another delegate from your company.